Metraipolis › archive › dc_cf11722fd0bc
BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility — Europe PMC PMID:42654399
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42654399
- DOI
- 10.3390/medicina62081502
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T03:08:43.550Z
- SHA-256 of the archived text
2cae0767f9bba1f27726d8e886db2e4712aa8f02004fe04f84ba089966b25da6- Stable URL of this page
https://metraipolis.com/documento/dc_cf11722fd0bc
How to cite
BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility — Europe PMC PMID:42654399 — Europe PMC (en), https://europepmc.org/article/MED/42654399 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf11722fd0bc (Metraipolis archive dc_cf11722fd0bc, sha256 2cae0767f9bba1f27726d8e886db2e4712aa8f02004fe04f84ba089966b25da6)
BibTeX
@misc{dccf11722fd0bc,
title = {BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility — Europe PMC PMID:42654399},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42654399},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf11722fd0bc; sha256 2cae0767f9bba1f27726d8e886db2e4712aa8f02004fe04f84ba089966b25da6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654399. Agents can read the archived copy with the MCP tool read_document.